Eplerenone Tablet, Film Coated
Product Images NDC 59762-1107

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Eplerenone (NDC 59762-1107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Eplerenone (Image 01)

Chemical structure of eplerenone, showing its steroidal framework with oxygen-containing functional groups including a lactone ring and ester moiety.*

FDA Label Image

Figure 1 (Image 02)

A Kaplan-Meier cumulative incidence curve comparing Eplerenone and placebo groups over approximately 27 months since randomization. The graph shows lower cumulative incidence percentages in the Eplerenone group than placebo, with risk numbers at various time points and a reported p-value of 0.008 and relative risk (RR) of 0.85 (95% CI, 0.75-0.96) shown on the chart.*

FDA Label Image

Figure 2 (Image 03)

A forest plot chart showing hazard ratios and 95% confidence intervals for various patient subgroups comparing Eplerenone versus placebo. Subgroups include overall mortality, age ranges, gender, race, diabetes status, hypertension history, Killip class, creatinine clearance levels, and baseline use of beta blockers, ACE inhibitors, digoxin, and diuretics. The x-axis ranges from 0 to 2, with indicators for 'Eplerenone Better' on the left and 'Placebo Better' on the right.*

FDA Label Image

Figure 3 (Image 04)

A dose-response scatter plot showing the placebo-subtracted adjusted mean change in trough cuff systolic blood pressure (SBP) for eplerenone in hypertension studies. The x-axis represents eplerenone dose in mg/day, ranging from 0 to 200 mg, and the y-axis shows SBP reduction in mmHg, ranging from 0 to 16. Data points are differentiated by study and dosing frequency, including Study 1 QD, Study 2 QD, and Study 2 BID.*

FDA Label Image

Figure 4 (Image 05)

A dose-response scatter plot showing the reduction in diastolic blood pressure (DBP) in mmHg on the vertical axis versus daily eplerenone dose in mg on the horizontal axis. Data points represent results from three hypertension studies with different dosing schedules, illustrating placebo-subtracted adjusted mean change from baseline.*

FDA Label Image

25 mg Container Label (Image 06)

Label for Eplerenone 25 mg film-coated tablets by Mylan Pharmaceuticals Inc., under Greenstone® brand. The package contains 30 tablets for oral use. Storage instructions specify 25°C with allowances between 15-30°C. Label includes NDC 59762-1107-2 and distributor information for Greenstone LLC, Morgantown, WV.*

FDA Label Image

50 mg Container Label (Image 07)

Eplerenone 50 mg oral film-coated tablets label with a 30-count package size. The label shows the Greenstone brand and includes storage instructions, dosage information, distributor details (Greenstone LLC), and a barcode. It states the prescription-only status and notes 50 mg eplerenone per tablet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.